Parexel International Corp (PRXL)

66.19
0.45 0.68
NASDAQ : Health Care
Prev Close 66.64
Open 66.62
Day Low/High 65.71 / 67.14
52 Wk Low/High 56.00 / 76.17
Volume 911.41K
Avg Volume 1.07M
Exchange NASDAQ
Shares Outstanding 50.95M
Market Cap 3.40B
EPS 2.90
P/E Ratio 23.72
Div & Yield N.A. (N.A)

Latest News

PAREXEL International To Present At Leerink Partners Healthcare Conference

PAREXEL International To Present At Leerink Partners Healthcare Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Leerink Partners Healthcare Conference on Thursday, February 16, 2017, in New York City.

Analysts' Actions -- Cabot, International Paper, Range Resources and More

Analysts' Actions -- Cabot, International Paper, Range Resources and More

Here are Monday's top research calls, including upgrades for Cabot Oil & Gas and Range Resources, and a downgrade for International Paper.

Analysts' Actions -- Eaton, Ford, Altria, Ralph Lauren and More

Analysts' Actions -- Eaton, Ford, Altria, Ralph Lauren and More

Here are Friday's top research calls, including an upgrade for Ford and downgrades for Eaton, Altria and Ralph Lauren.

PAREXEL International Reports Second Quarter Fiscal Year 2017 Results

PAREXEL International Reports Second Quarter Fiscal Year 2017 Results

PAREXEL International Corporation (NASDAQ: PRXL) today reported financial results for the second quarter of Fiscal Year 2017, which ended on December 31, 2016.

PAREXEL Announces Definitive Agreement To Acquire The Medical Affairs Company

PAREXEL Announces Definitive Agreement To Acquire The Medical Affairs Company

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that the Company has entered into a definitive agreement to acquire The Medical Affairs Company, LLC...

PAREXEL's Albert Siu And Anke Nissen Accept A 2017 Training Magazine Training Top 125 Award On Behalf Of The Company. PAREXEL Ranked 38 Among The Top 125 Companies. (Photo: Business Wire)

PAREXEL's Albert Siu And Anke Nissen Accept A 2017 Training Magazine Training Top 125 Award On Behalf Of The Company. PAREXEL Ranked 38 Among The Top 125 Companies. (Photo: Business Wire)

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that the Company has been recognized among top U.

PAREXEL Expands Managed Access Programs Service Offering

PAREXEL Expands Managed Access Programs Service Offering

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched an expanded Managed Access Programs service.

PAREXEL International Announces Date Of Second Quarter Fiscal Year 2017 Earnings Release And Conference Call

PAREXEL International Announces Date Of Second Quarter Fiscal Year 2017 Earnings Release And Conference Call

PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Second Quarter Fiscal Year 2017 on Wednesday, February 1, 2017 after the close of the stock market.

PAREXEL International To Present At JP Morgan Healthcare Conference

PAREXEL International To Present At JP Morgan Healthcare Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the JP Morgan Healthcare Conference on Tuesday, January 10, 2017, in San Francisco.

PAREXEL International Announces $200 Million Accelerated Share Repurchase Program

PAREXEL International Announces $200 Million Accelerated Share Repurchase Program

PAREXEL International Corporation (Nasdaq:PRXL), a leading global biopharmaceutical services provider, announced today that the Company entered into an accelerated share repurchase agreement (ASR) with HSBC Bank USA,...

PAREXEL International To Participate In Evercore ISI MedTools Conference

PAREXEL International To Participate In Evercore ISI MedTools Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be attending the Evercore ISI MedTools Conference in Boston.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Violations Of Federal Securities Laws By Certain Officers And Directors Of PAREXEL International Corporation

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Violations Of Federal Securities Laws By Certain Officers And Directors Of PAREXEL International Corporation

Levi & Korsinsky announces it has commenced an investigation of PAREXEL International Corporation (NASDAQ: PRXL) ("PAREXEL") concerning possible violations of federal securities laws by the Company and/or certain of its...

PAREXEL Launches IDMP-Focused Software And Service Solution

PAREXEL Launches IDMP-Focused Software And Service Solution

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched an Identification of Medicinal Products (IDMP)-focused solution for biopharmaceutical companies.

EQUITY ALERT: Goldberg Law PC Announces An Investigation Of Claims Against PAREXEL International Corporation And Advises Investors With Losses To Contact The Firm

EQUITY ALERT: Goldberg Law PC Announces An Investigation Of Claims Against PAREXEL International Corporation And Advises Investors With Losses To Contact The Firm

Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating PAREXEL International Corporation ("PAREXEL" or the "Company") (Nasdaq: PRXL) concerning possible violations of federal...

INVESTOR LOSS ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against PAREXEL International Corporation - PRXL

INVESTOR LOSS ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against PAREXEL International Corporation - PRXL

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of PAREXEL International Corporation (NASDAQ:PRXL) resulting from allegations that...

3 Small Cap Stocks Worth Considering

3 Small Cap Stocks Worth Considering

The market's minnows are swimming away from its whales as the Russell 2000 Index is up about 8% compared with the 5% gain in the S&P 500.

PAREXEL International Reports First Quarter Fiscal Year 2017 Results And Announces New Share Repurchase Program

PAREXEL International Reports First Quarter Fiscal Year 2017 Results And Announces New Share Repurchase Program

PAREXEL International Corporation (NASDAQ: PRXL) today reported financial results for the first quarter of Fiscal Year 2017, which ended on September 30, 2016.

PAREXEL International To Present At Credit Suisse Healthcare Conference

PAREXEL International To Present At Credit Suisse Healthcare Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Credit Suisse Healthcare Conference in Phoenix, AZ.

3 Small Cap Stocks Which Could be Worth Snapping Up

3 Small Cap Stocks Which Could be Worth Snapping Up

Parexel, G-III and Quaker Chemical are small caps to watch as the market's minnows outswim its whales.

Short Interest Increases 16% For PRXL

Short Interest Increases 16% For PRXL

The most recent short interest data has been released for the 09/30/2016 settlement date, which shows a 556,464 share increase in total short interest for PAREXEL International Corp. , to 4,007,342, an increase of 16.13% since 09/15/2016.

PAREXEL International Announces Date Of First Quarter Fiscal Year 2017 Earnings Release And Conference Call

PAREXEL International Announces Date Of First Quarter Fiscal Year 2017 Earnings Release And Conference Call

PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for First Quarter Fiscal Year 2017 on Wednesday, October 26, 2016 after the close of the stock market.

PAREXEL Launches Active Tracking Service For Monitoring And Managing Temperature-Controlled Investigational Medicinal Products

PAREXEL Launches Active Tracking Service For Monitoring And Managing Temperature-Controlled Investigational Medicinal Products

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced the launch of its Active Tracking service.